Your browser doesn't support javascript.
loading
Factors associated with viral rebound among COVID-19 patients receiving oral antivirals.
Chen, Pao-Yu; Wang, Jann-Tay; Chang, Sui-Yuan; Hung, Chien-Ching; Fang, Chi-Tai; Cheng, Aristine; Liu, Wang-Da; Huang, Yu-Shan; Lin, Kuan-Yin; Sun, Hsin-Yun; Pan, Sung-Ching; Cheng, Yu-Cheng; Wang, Hurng-Yi; Sheng, Wang-Huei; Chen, Yee-Chun; Ho, Yi-Lwun; Wu, Ming-Shiang; Chang, Shan-Chwen.
Afiliación
  • Chen PY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Wang JT; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; National Institutes of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan. Electronic address: wanjt.1968@gmail.com.
  • Chang SY; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Hung CC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Tropical Medicine and Parasitology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwa
  • Fang CT; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
  • Cheng A; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Liu WD; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Huang YS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Lin KY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Sun HY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Pan SC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Cheng YC; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Wang HY; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Sheng WH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Chen YC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; National Institutes of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Ho YL; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Wu MS; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Chang SC; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
J Formos Med Assoc ; 122(8): 766-775, 2023 Aug.
Article en En | MEDLINE | ID: mdl-36934018

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Formos Med Assoc Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Formos Med Assoc Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Taiwán